Meridian Bioscience, Inc. (NASDAQ:VIVO)
A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
mackfack
(93.13)
Submitted: 10/25/2012 4:04:11 PM :
Start Price:
$12.94
VIVO Score:
+35.38
Coming out of a trough that lasted 2-3 years. New platforms and realigned resources are ready to run...
Recs
TempoAllegro
(49.16)
Submitted: 9/12/2012 9:57:29 AM :
Start Price:
$17.72
VIVO Score:
+8.97
VIVO makes a range of diagnostic tests for foodborne, parasitic, viral, and other diseases that you can do at home. The kits are now available in North America, Europe, Africa, and the Middle East.
With increasing threats to the food supply and environmental concerns such as lack of proper water for both humans and livestock, these tests will be both helpful and in greater demand in coming years.
Add to that its great balance sheet - currently with zero debt and current ratio of over 5, plus high insider ownership, generous dividend, and 5-year projected growth in the mid-teens, and we have an excellent addition to anyone's health-oriented portfolio.
Recs
Recs
Recs
BrodieMan720
(95.60)
Submitted: 9/19/2010 5:20:13 PM :
Start Price:
$18.92
VIVO Score:
-30.72
Very solid looking company. Nice quick ratio and strong returns make it very appealing. Decent dividend, too. Not really sure of what sort of things they have in the pipeline, but their core business seems to be doing well. Very nice growth rates top it off.
Recs
elvisbeatlesfan
(85.70)
Submitted: 8/31/2010 2:37:57 AM :
Start Price:
$17.40
VIVO Score:
-13.41
Growth company that is also growing it's dividend. Also might be a takeover target in foreseeable future.
Recs
benbanner
(65.20)
Submitted: 8/19/2010 1:14:23 PM :
Start Price:
$16.94
VIVO Score:
-23.99
Good fundamentals...no LT debt, div paying stock.
Recs
jrwatkins2008
(83.83)
Submitted: 5/8/2010 9:38:24 PM :
Start Price:
$17.05
VIVO Score:
-14.36
No debt a lot of cash high yield won't go down as much over the next 2-3 months and will come back strong
Recs
jamesm113
(< 20)
Submitted: 3/22/2010 3:21:28 PM :
Start Price:
$18.47
VIVO Score:
-23.07
h1n1 or some other virus will be back. long term buy.
Recs
TraderHater
(42.95)
Submitted: 3/17/2010 6:27:42 PM :
Start Price:
$17.51
VIVO Score:
-16.14
There's always next season's pandemic to consider, long term buy
Recs
geomanpa
(< 20)
Submitted: 8/24/2009 9:59:51 PM :
Start Price:
$20.86
VIVO Score:
-55.79
Awesome management
Recs
vgaymer
(28.79)
Submitted: 4/12/2009 4:55:58 PM :
Start Price:
$15.05
VIVO Score:
-51.29
msn screen:
5 year div. growth >= 20 %
annual eps growth >= 25%
debt/eq <= 0.5
current dividend >= 2.5%
Recs
Money4e
(44.40)
Submitted: 3/20/2009 7:47:01 AM :
Start Price:
$15.06
VIVO Score:
-66.74
Rapid testing products for medical conditions. Help keep malpractice rates down and is becoming cheaper. Get's the patient tested for certain illnesses quickly which means earlier treatment, which means cheaper for the medical company
Recs
DODEA
(76.07)
Submitted: 12/29/2008 11:53:02 AM :
Start Price:
$13.29
VIVO Score:
+40.88
Meridian Biosciences has been a great pick for me since 1989. It was one of the very first stocks I owned, and my second DRIP. It has very strong financials, an intelligent business plan, and many products in its pipeline. This is an excellent small-cap stock for getting in on the ground floor.
Recs
WilliamCrook2007
(< 20)
Submitted: 11/20/2008 2:47:04 PM :
Start Price:
$19.59
VIVO Score:
-102.97
ibd
Recs
moof77
(51.43)
Submitted: 11/11/2008 3:22:24 AM :
Start Price:
$19.57
VIVO Score:
-74.81
Well managed company whose products will only see more demand in coming years.
Recs
CKENNED2
(< 20)
Submitted: 9/24/2008 11:20:43 PM :
Start Price:
$23.94
VIVO Score:
-50.50
MERIDIAN IS POISED TO GAIN NEW BUSINESS UNFORTOLD
Recs
diva27
(45.48)
Submitted: 9/17/2008 9:19:31 AM :
Start Price:
$22.77
VIVO Score:
-46.35
Vivo's services are always going to be necessary, the world is not exactly getting healthier and healthier. They presently have good numbers and have shown some growth in the past. I'm confident that this is one of those stocks to watch.
Recs
hiBo
(95.29)
Submitted: 6/16/2008 12:51:01 AM :
Start Price:
$25.62
VIVO Score:
-40.34
excellent financials. high percentage of insider ownership
Recs
healthcareinvest
(50.58)
Submitted: 5/5/2008 1:42:30 PM :
Start Price:
$23.36
VIVO Score:
-28.13
Most robust point of care testing portfolio- growth not likely to slow much given the diverse lab tests available- life science sector should improve over time.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 61 : 1 2 3 4 Next »